Changes in nocturia after photoselective vaporization of the prostate for patients with benign prostatic hyperplasia

Korean Journal of Urology

Volumn 51, Issue 8, 2010, Pages 531-536

  Lee, Chang Ju ^a   Cho, Min Chul ^b   Ku, Ja Hyeon ^a   Kim, Soo Woong ^a   Paick, Jae Seung ^a  

^a Seoul National University   (South Korea)

^b Dongguk University College of Medicine   (South Korea)

Author keywords

Laser therapy; Nocturia; Prostatic hyperplasia

Indexed keywords

AGED; ARTICLE; BLADDER CAPACITY; DETRUSOR MUSCLE; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; NOCTURIA; PHOTOSELECTIVE VAPORIZATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROSTATE HYPERTROPHY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; URODYNAMICS;

EID: 77955858276     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2010.51.8.531     Document Type: Article

References (26)

1. van Kerrebroeck P, Abrams P, Chaikin D, Donovan J, Fonda D, Jackson S, et al. The standardization of terminology in nocturia: report from the standardization subcommittee of the International Continence Society. BJU Int 2002;90(Suppl 3):11-5.
2. Asplund R. Mortality in the elderly in relation to nocturnal micturition. BJU Int 1999;84:297-301.
3. Stewart RB, Moore MT, May FE, Marks RG, Hale WE. Nocturia: a risk factor for falls in the elderly. J Am Geriatr Soc 1992;40: 1217-20.
4. Abrams P. Nocturia: the major problem in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (LUTS/BPO). Eur Urol 2005;3(Suppl 6):8-16.
5. Yoshimura K, Ohara H, Ichioka K, Terada N, Matsui Y, Terai A, et al. Nocturia and benign prostatic hyperplasia. Urology 2003;61:786-90.
6. Homma Y, Yamaguchi T, Kondo Y, Horie S, Takahashi S, Kitamura T. Significance of nocturia in the International Prostate Symptom Score for benign prostatic hyperplasia. J Urol 2002;167:172-6.
7. Eckhardt MD, van Venrooij GE, Boon TA. Symptoms and quality of life versus age, prostate volume, and urodynamic parameters in 565 strictly selected men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Urology 2001;57:695-700.
8. Seki N, Yuki K, Takei M, Yamaguchi A, Naito S. Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction. Neurourol Urodyn 2009;28:197-201.
9. Margel D, Lifshitz D, Brown N, Lask D, Livne PM, Tal R. Predictors of nocturia quality of life before and shortly after prostatectomy. Urology 2007;70:493-7.
10. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 2004:172: 1404-8.
11. Bachmann A, Schürch L, Ruszat R, Wyler SF, Seifert HH, Müller A, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005;48:965-71.
12. Malek RS, Kuntzman RS, Barrett DM. Photoselective potassium-titanyl- phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol 2005;174:1344-8.
13. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int 2006;97:1229-33.
14. Paick JS, Um JM, Kwak C, Kim SW, Ku JH. Influence of bladder contractility on short-term outcomes of high-power potassium-titanyl- phosphate photoselective vaporization of the prostate. Urology 2007;69:859-63.
15. Weiss JP, Blaivas JG, Stember DS, Chaikin DC. Evaluation of the etiology of nocturia in men: the nocturia and nocturnal bladder capacity indices. Neurourol Urodyn 1999;18:559-65.
16. Lim CS, Abrams P. The Abrams-Griffiths nomogram. World J Urol 1995;13:34-9.
17. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21: 167-78.
18. Middelkoop HA, Smilde-van den Doel DA, Neven AK, Kamphuisen HA, Springer CP. Subjective sleep characteristics of 1,485 males and females aged 50-93: effects of sex and age, and factors related to self-evaluated quality of sleep. J Gerontol A Biol Sci Med Sci 1996;51:M108-15.
19. Blanker MH, Bohnen AM, Groeneveld FP, Bernsen RM, Prins A, Ruud Bosch JL. Normal voiding patterns and determinants of increased diurnal and nocturnal voiding frequency in elderly men. J Urol 2000;164:1201-5.
20. Andersson KE. Storage and voiding symptoms: pathophysiologic aspects. Urology 2003;62(5 Suppl 2):3-10.
21. Abrams PH. The pathophysiology of male bladder outflow obstruction. In: Whitfield HN, Hendry WF, editors. Textbook of genito-urinary surgery. Edinburgh: Churchill Livingstone; 1985; 3760-84.
22. Harrison SC, Hunnam GR, Farman P, Ferguson DR, Doyle PT. Bladder instability and denervation in patients with bladder outflow obstruction. Br J Urol 1987;60:519-22.
23. Cumming JA, Chisholm GD. Changes in detrusor innervation with relief of outflow tract obstruction. Br J Urol 1992;69:7-11.
24. Steers WD. Pathophysiology of overactive bladder and urge urinary incontinence. Rev Urol 2002;4(Suppl 4):S7-18.
25. Housami F, Abrams P. Persistent detrusor overactivity after transurethral resection of the prostate. Curr Urol Rep 2008;9: 284-90.
26. McCormack M, Infante-Rivard C, Schick E. Agreement between clinical methods of measurement of urinary frequency and functional bladder capacity. Br J Urol 1992;69:17-21.